Join the Soft Tissue Sarcoma group to help and get support from people like you.
Soft Tissue Sarcoma News
Related terms: Alveolar rhabdomyosarcoma, Cancer, Rhabdomyosarcoma, Cancer, Soft Tissue Sarcoma, Embryonal rhabdomyosarcoma, Sarcoma botryoides
Incidence Rates of Soft Tissue Sarcoma Lower in Servicemen
MONDAY, Dec. 9, 2024 – The incidence rates of soft tissue sarcoma (STS) are lower among servicemen than men in the general U.S. population, according to a study published online Dec. 9 in Cancer....
FDA Grants Accelerated Approval to Lartruvo (olaratumab) for Advanced Soft Tissue Sarcoma
October 19, 2016 – The U.S. Food and Drug Administration today granted accelerated approval to Lartruvo (olaratumab) with doxorubicin to treat adults with certain types of soft tissue sarcoma (STS),...
FDA Approves Halaven (eribulin mesylate) for the Treatment of Liposarcoma
January 28, 2016 – The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate), a type of chemotherapy, for the treatment of liposarcoma (a specific type of soft tissue sarcoma)...
FDA Approves Yondelis (trabectedin) for the Treatment of Specific Soft Tissue Sarcomas
October 23, 2015 - The U.S. Food and Drug Administration today approved Yondelis (trabectedin), a chemotherapy, for the treatment of specific soft tissue sarcomas (STS) – liposarcoma and l...
FDA Approves Votrient for Advanced Soft Tissue Sarcoma
April 26, 2012 – The U.S. Food and Drug Administration today approved Votrient (pazopanib) to treat patients with advanced soft tissue sarcoma who have previously received chemotherapy. Soft tissue...